PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Individuals with PNPLA3 I148M variants, associated with non-alcoholic fatty liver disease, demonstrate differential methylation responses to dietary choline and fermented foods, suggesting that epigenetic regulation may mediate gene–diet effects on liver health [15,16].